does medicaid cover glp-1 Navigating Changes to Medication Coverage States Are Walking Back Medicaid

Fatigue affects roughly 13% of users during the first month, often related to reduced caloric intake as appetite suppression takes effect

Currently, Murielle and her team are focused on the clinical development of the novel multispecific molecule AMG 133

Weight loss Available in NZ = Liraglutide high dose (Saxenda, daily injection) Self-funding needed ($500-600/month) Not available in NZ = Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro), as of May 2023 Side effects, particularly upper gastrointestinal, are common with GLP-1 agonist initiation

Diabetes Obes Metab 24(8):15531564 Wharton S et al (2021) Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data

medRxiv 26(9):39063913 [DOI] [PMC free article] [PubMed] [Google Scholar] 72.Wharton S et al (2019) The effectiveness and safety of pharmaceuticals to manage excess weight post-bariatric surgery: a systematic literature review

They also slow progression of diabetic kidney disease and are associated with beneficial effects like lower blood pressure and improved lipid profiles ( [8] ) ( [7] )